Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Bolton Medical, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Bolton Medical, Inc.

Regulatory records
17
Linked recall entries
1
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 17 FDA records to the applicant name Bolton Medical, Inc.. It includes 1 original PMA approval. 7 entries are PMA supplements. 9 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Aug 5, 2021 to Oct 28, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MIH appears in 17 of the 17 linked filings. The collection spans 1 FDA product code and 3 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P200045, with 9 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 2 linked filings have a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 799 International Pkwy., Sunrise, FL, 33325. Recorded on P200045/S025, decision dated Oct 28, 2026.

Changes described in PMA records

P200045/S025: RelayPro Thoracic Stent-Graft Delivery System

FDA recorded a 30-Day Notice decision coded OK30 on 2026-10-28 for supplement P200045/S025 to PMA P200045, submitted by Bolton Medical, Inc. for the RelayPro Thoracic Stent-Graft Delivery System. The supplement type is listed as a 30-Day Notice with the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the recorded statement describes combining two delivery system components into a single component for the RelayPro Thoracic Stent-Graft System.

The record covers a manufacturing process change to the delivery system rather than a new approval of the full stent-graft system, and the source does not describe the affected components, the sterilization or packaging sites involved, or any conditions attached to the decision. The device category is listed as SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT, with Cardiovascular specialty and product code MIH. No supporting documents were included, so the basis for OK30 and any clinical implications remain unknown from this record.

FDA approval-order wording

combination of two delivery system components into a single component for the RelayPro Thoracic Stent-Graft System

Oct 28, 2026 · 30-Day Notice

P190015/S030: TREO Abdominal Stent-Graft System

FDA’s recorded scope: addition of a routine bacterial endotoxin testing facility for the RelayPro Thoracic Stent-Graft System and the TREO Abdominal Stent-Graft System

Jun 18, 2026 · 30-Day Notice

P190015/S024: TREO Abdominal Stent-Graft System

FDA’s recorded scope: Approval for a change in the inner liner material of the introducer sheath for the RelayPro Thoracic Stent-Graft System and TREO Abdominal Stent-Graft System.

Apr 13, 2026 · Normal 180 Day Track

P200045/S017: RelayPro Thoracic Stent-Graft System

FDA’s recorded scope: Approval for a change in the inner liner material of the introducer sheath for the RelayPro Thoracic Stent-Graft System and TREO Abdominal Stent-Graft System.

Apr 13, 2026 · Normal 180 Day Track

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

RECALL COVERAGE

Recalls linked to this firm

MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class I records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.

Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.

Source information

Source updated Nov 11, 2026. Retrieved Nov 21, 2026.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Bolton Medical, Inc.PMA supplementOct 28, 2026FDA
Bolton Medical, Inc.PMA supplementJun 18, 2026FDA
Bolton Medical, Inc.PMA supplementJun 18, 2026FDA
Bolton Medical, Inc.PMA supplementApr 13, 2026FDA
Bolton Medical, Inc.PMA supplementApr 13, 2026FDA
Bolton Medical, Inc.PMA supplementMar 26, 2026FDA
Bolton Medical, Inc.PMA supplementFeb 19, 2026FDA
Bolton Medical, Inc.PMA supplementFeb 19, 2026FDA
Bolton Medical, Inc.PMA supplementFeb 18, 2026FDA
Bolton Medical, Inc.PMA supplementOct 10, 2025FDA
Bolton Medical, Inc.PMA supplementOct 7, 2025FDA
Bolton Medical, Inc.PMA supplementSep 10, 2025FDA
Bolton Medical, Inc.PMA supplementSep 3, 2025FDA
RelayProP200045/S019
Bolton Medical, Inc.PMA supplementSep 3, 2025FDA
RelayPlusP110038/S034
Bolton Medical, Inc.PMA supplementSep 3, 2025FDA
Bolton Medical, Inc.PMA supplementJul 22, 2025FDA
Bolton Medical, Inc.PMA approvalAug 5, 2021FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.